A phase 2 study of the combination dostarlimab with niraparib in patients with penile carcinoma that has progressed following chemotherapy.
Authors:
- 1 February 2024
- journal article
- abstracts
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 42 (4_suppl) , TPS13
Abstract
No abstract availableKeywords
Funding Information
- DOD Grant supporting correlative work (HT94252310613)
- GlaxoSmithKline